Ipilimumab vs Nitroglycerin

## Ipilimumab vs Nitroglycerin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Nitroglycerin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Nitroglycerin**: Nitric oxide donor causing venous and arterial vasodilation.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Nitroglycerin — 1-4 minutes.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Nitroglycerin — C3H5N3O9.

**Molecular Weight**: Ipilimumab — N/A; Nitroglycerin — 227.0870 g/mol.

**Type**: Ipilimumab — Antibody; Nitroglycerin — Small molecule.